Last reviewed · How we verify
7-day quadruple therapy
At a glance
| Generic name | 7-day quadruple therapy |
|---|---|
| Also known as | Pantoprazole, amoxicillin, clarithromycin, metronidazole |
| Sponsor | Kaohsiung Veterans General Hospital. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial (PHASE3)
- Fecal Molecular Susceptibility-guided Hp First-line Therapy (PHASE4)
- Fecal Molecular Susceptibility-guided Hp Rescue Therapy (PHASE4)
- Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy (PHASE2)
- A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children (NA)
- Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) (PHASE2)
- Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori (NA)
- Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 7-day quadruple therapy CI brief — competitive landscape report
- 7-day quadruple therapy updates RSS · CI watch RSS
- Kaohsiung Veterans General Hospital. portfolio CI